Clinical Trials Browser

Locally Recurrent Skin Squamous Cell Carcinoma × Cetuximab × 1 year × Clear all

NCT07042295 2026-03-18

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

Phase 2 Recruiting

Locally Recurrent Skin Squamous Cell Carcinoma